Skip to content
Dr Zarir F. Udwadia
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates
Menu

The added effect of thioridazine in the treatment of drug-resistant tuberculosis.

Go to Publication

You Might Also Like

Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.

October 19, 2015

Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic.

August 30, 2019

Autonomous dysfunction in severe tetanus.

November 6, 1990

Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6].

September 5, 2016

Denying access to bedaqualine in India costs lives.

August 17, 2017

Hinduja Hospital,

Mahim, Mumbai – 400016

Appointment –
022 45108181, 022 67668181

Office – 022 24447353

Breach Candy Hospital,

B. Desai Road, Mumbai – 400026

Appointment – 5-8 pm
022 23667900
022 23667995

 

Thomas Cook Building,

DN Road, Mumbai – 400001

Appointment – After 6 pm
022 22046210
022 67439337

Copyright 2021 - Dr.Zarir Udwadia
Close Menu